Benign Prostatic Hyperplasia Treatment Market In-depth Research covering sales outlook, demand forecast & up-to-date key trends
The global Benign Prostatic Hyperplasia Treatment market is expected to grow at a CAGR of 3.5% during the forecast period.
The global Benign Prostatic Hyperplasia Treatment market is estimated to be about 6137.7 million US dollars in 2020.
The global Benign Prostatic Hyperplasia Treatment market is estimated to reach 7050.5 million USD by 2026.
The global Benign Prostatic Hyperplasia Treatment market is segmented by company, region (country), type and application. Participants, stakeholders, and other readers in the global Benign Prostatic Hyperplasia Treatment market will be able to gain an advantage as they use reports as a powerful resource.
Benign Prostatic Hyperplasia Treatment markets by category
Drug Class
Minimally Invasive Surgeries
Laser Therapy
Others
Benign Prostatic Hyperplasia Treatment Market by Application (Percentage of Demand)
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Others
Who are the leading companies in Benign Prostatic Hyperplasia Treatment
Abbott
Allergan plc
Astellas Pharma
Asahi Kasei Corporation
Boehringer Ingelheim GmbH
GlaxoSmithKline
Pfizer
Sanofi
Teva Pharmaceutical Industries
Merck
Boston Scientific Corporation
Teleflex Incorporated
Endo International
Urologix
LISA Laser
Olympus
Benign Prostatic Hyperplasia Treatment markets by region:
In North America
In Latin America
Europe
The Asia-pacific
Middle East and Africa (MEA)
What are the main countries covered
The United States
Canada
Germany
France
UK
Italy
Russia
China
Japan
Korea
Southeast Asia
India
Australia
Brazil
Mexico
Argentina
Chile
Colombia
Egypt
Saudi Arabia
United Arab Emirates
Nigeria
South Africa
Which is the most profitable market
Among regions, North America/Europe/Asia Pacific accounted for the largest share of global personalized beauty equipment as rising consumer incomes led to increased spending at Benign Prostatic Hyperplasia Treatment.
What methodology did you follow in your research
This study was conducted by our expert analysts through a combination of primary and secondary studies. The methodology we follow includes a demand-side assessment of the market and triangulation of this through supply-side analysis. The methodology is based on the use of standard market structures, methods, and definitions.
Who were the primary study respondents
We talk to stakeholders across the spectrum. Including C-level executives, distributors, product manufacturers, industry experts, etc.
What are the sources of secondary research
We conduct extensive secondary studies using proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations and research papers.
1. Introduction
1.1 Definition of the Market
1.2 Research Purpose
1.3 Scope of the Study
1.4 Stakeholders
1.5 Geography Coverage
1.6 Currency Under Consideration
1.7 Market Size Units
1.8 Review Cycle
2 Global Market Overview
2.1 Global Benign Prostatic Hyperplasia Treatment Revenue and Growth Forecast 2014-2026
2.2 Global Benign Prostatic Hyperplasia Treatment Market Size and Growth Forecast 2014-2026
2.3 Global Benign Prostatic Hyperplasia Treatment Revenue by Region 2014-2026
2.4 Benign Prostatic Hyperplasia Treatment Market Share by Major Regions 2014-2021
2.5 Benign Prostatic Hyperplasia Treatment Gross Margin in Different Region 2014-2021
2.6 Global Benign Prostatic Hyperplasia Treatment Market History Price and Forecast 2014-2026
2.7 Global Benign Prostatic Hyperplasia Treatment Sales Market Share by Top Companies 2014-2021
3 Global Benign Prostatic Hyperplasia Treatment Market by Type
3.1 Global Benign Prostatic Hyperplasia Treatment Revenue and Growth Rate Segment by Types from 2014-2021
3.2 Global Benign Prostatic Hyperplasia Treatment Market Size and Growth Rate Segment by Product Types from 2014-2021
3.3 Global Benign Prostatic Hyperplasia Treatment Price Segment by Types from 2014-2021
3.4 Brief Introduction of Different Types
3.4.1 Drug Class
3.4.2 Minimally Invasive Surgeries
3.4.3 Laser Therapy
3.4.4 Others
4 Global Benign Prostatic Hyperplasia Treatment Market by Application
4.1 Global Benign Prostatic Hyperplasia Treatment Revenue and Growth Rate Segment by Applications from 2014-2021
4.2 Global Benign Prostatic Hyperplasia Treatment Market Size and Growth Rate Segment by Product Applications from 2014-2021
4.3 Brief Introduction of Different Applications
4.3.1 Hospitals
4.3.2 Ambulatory Surgical Centers
4.3.3 Specialty Clinics
4.3.4 Others
5 North America Benign Prostatic Hyperplasia Treatment Market (Value, Market Size, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
5.1 North America Benign Prostatic Hyperplasia Treatment Value ($) from 2014-2021
5.2 North America Benign Prostatic Hyperplasia Treatment Market Size from 2014-2021
5.3 North America Benign Prostatic Hyperplasia Treatment Price Change from 2014-2021
5.4 North America Benign Prostatic Hyperplasia Treatment Import and Export from 2014-2021
5.5 North America Benign Prostatic Hyperplasia Treatment Market Value ($) and Growth (%) by Type from 2014-2021
5.6 North America Benign Prostatic Hyperplasia Treatment Market Value ($) and Growth (%) by Application from 2014-2021
5.7 North America Benign Prostatic Hyperplasia Treatment Market Value ($) and Growth (%) by Countries from 2014-2021
5.7.1 The United States
5.7.2 Canada
5.8 Top North America Benign Prostatic Hyperplasia Treatment Participants Value ($) and Market Share (%) in 2020
6 Europe Benign Prostatic Hyperplasia Treatment Market (Value, Market Size, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
6.1 Europe Benign Prostatic Hyperplasia Treatment Value ($) from 2014-2021
6.2 Europe Benign Prostatic Hyperplasia Treatment Market Size from 2014-2021
6.3 Europe Benign Prostatic Hyperplasia Treatment Price Change from 2014-2021
6.4 Europe Benign Prostatic Hyperplasia Treatment Import and Export from 2014-2021
6.5 Europe Benign Prostatic Hyperplasia Treatment Market Value ($) and Growth (%) by Type from 2014-2021
6.6 Europe Benign Prostatic Hyperplasia Treatment Market Value ($) and Growth (%) by Application from 2014-2021
6.7 Europe Benign Prostatic Hyperplasia Treatment Market Value ($) and Growth (%) by Countries from 2014-2021
6.7.1 Germany
6.7.2 France
6.7.3 UK
6.7.4 Italy
6.7.5 Russia
…
6.8 Top Europe Benign Prostatic Hyperplasia Treatment Participants Value ($) and Market Share (%) in 2020
7 Asia-Pacific Benign Prostatic Hyperplasia Treatment Market (Value, Market Size, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
7.1 Asia-Pacific Benign Prostatic Hyperplasia Treatment Value ($) from 2014-2021
7.2 Asia-Pacific Benign Prostatic Hyperplasia Treatment Market Size from 2014-2021
7.3 Asia-Pacific Benign Prostatic Hyperplasia Treatment Price Change from 2014-2021
7.4 Asia-Pacific Benign Prostatic Hyperplasia Treatment Import and Export from 2014-2021
7.5 Asia-Pacific Benign Prostatic Hyperplasia Treatment Market Value ($) and Growth (%) by Type from 2014-2021
7.6 Asia-Pacific Benign Prostatic Hyperplasia Treatment Market Value ($) and Growth (%) by Application from 2014-2021
7.7 Asia-Pacific Benign Prostatic Hyperplasia Treatment Market Value ($) and Growth (%) by Countries from 2014-2021
7.7.1 China
7.7.2 Japan
7.7.3 Korea
7.7.4 Southeast Asia
7.7.5 India
7.7.6 Australia
…
7.8 Top Asia-Pacific Benign Prostatic Hyperplasia Treatment Participants Value ($) and Market Share (%) in 2020
8 Latin America Benign Prostatic Hyperplasia Treatment Market (Value, Market Size, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
8.1 Latin America Benign Prostatic Hyperplasia Treatment Value ($) from 2014-2021
8.2 Latin America Benign Prostatic Hyperplasia Treatment Market Size from 2014-2021
8.3 Latin America Benign Prostatic Hyperplasia Treatment Price Change from 2014-2021
8.4 Latin America Benign Prostatic Hyperplasia Treatment Import and Export from 2014-2021
8.5 Latin America Benign Prostatic Hyperplasia Treatment Market Value ($) and Growth (%) by Type from 2014-2021
8.6 Latin America Benign Prostatic Hyperplasia Treatment Market Value ($) and Growth (%) by Application from 2014-2021
8.7 Latin America Benign Prostatic Hyperplasia Treatment Market Value ($) and Growth (%) by Countries from 2014-2021
8.7.1 Brazil
8.7.2 Mexico
8.7.3 Argentina
8.7.4 Chile
8.7.5 Colombia
…
8.8 Top Latin America Benign Prostatic Hyperplasia Treatment Participants Value ($) and Market Share (%) in 2020
9 Middle East & Africa Benign Prostatic Hyperplasia Treatment Market (Value, Market Size, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
9.1 Middle East & Africa Benign Prostatic Hyperplasia Treatment Value ($) from 2014-2021
9.2 Middle East & Africa Benign Prostatic Hyperplasia Treatment Market Size from 2014-2021
9.3 Middle East & Africa Benign Prostatic Hyperplasia Treatment Price Change from 2014-2021
9.4 Middle East & Africa Benign Prostatic Hyperplasia Treatment Import and Export from 2014-2021
9.5 Middle East & Africa Benign Prostatic Hyperplasia Treatment Market Value ($) and Growth (%) by Type from 2014-2021
9.6 Middle East & Africa Benign Prostatic Hyperplasia Treatment Market Value ($) and Growth (%) by Application from 2014-2021
9.7 Middle East & Africa Benign Prostatic Hyperplasia Treatment Market Value ($) and Growth (%) by Countries from 2014-2021
9.7.1 Egypt
9.7.2 Saudi Arabia
9.7.3 United Arab Emirates
9.7.4 Nigeria
9.7.5 South Africa
…
9.8 Top Middle East & Africa Benign Prostatic Hyperplasia Treatment Participants Value ($) and Market Share (%) in 2020
10. Global Level Competitive Intelligence – Company Profiles
10.1 Abbott
10.1.1 Abbott Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.1.2 Abbott Sales, Value, Gross and Gross Margin from 2014-2021
10.1.3 Abbott Value and Growth Change from 2014-2021
10.1.4 Abbott Price Change from 2014-2021
10.1.5 Abbott Product Offered
10.2 Allergan plc
10.2.1 Allergan plc Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.2.2 Allergan plc Sales, Value, Gross and Gross Margin from 2014-2021
10.2.3 Allergan plc Value and Growth Change from 2014-2021
10.2.4 Allergan plc Price Change from 2014-2021
10.2.5 Allergan plc Product Offered
10.3 Astellas Pharma
10.3.1 Astellas Pharma Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.3.2 Astellas Pharma Sales, Value, Gross and Gross Margin from 2014-2021
10.3.3 Astellas Pharma Value and Growth Change from 2014-2021
10.3.4 Astellas Pharma Price Change from 2014-2021
10.3.5 Astellas Pharma Product Offered
10.4 Asahi Kasei Corporation
10.4.1 Asahi Kasei Corporation Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.4.2 Asahi Kasei Corporation Sales, Value, Gross and Gross Margin from 2014-2021
10.4.3 Asahi Kasei Corporation Value and Growth Change from 2014-2021
10.4.4 Asahi Kasei Corporation Price Change from 2014-2021
10.4.5 Asahi Kasei Corporation Product Offered
10.5 Boehringer Ingelheim GmbH
10.5.1 Boehringer Ingelheim GmbH Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.5.2 Boehringer Ingelheim GmbH Sales, Value, Gross and Gross Margin from 2014-2021
10.5.3 Boehringer Ingelheim GmbH Value and Growth Change from 2014-2021
10.5.4 Boehringer Ingelheim GmbH Price Change from 2014-2021
10.5.5 Boehringer Ingelheim GmbH Product Offered
10.6 GlaxoSmithKline
10.6.1 GlaxoSmithKline Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.6.2 GlaxoSmithKline Sales, Value, Gross and Gross Margin from 2014-2021
10.6.3 GlaxoSmithKline Value and Growth Change from 2014-2021
10.6.4 GlaxoSmithKline Price Change from 2014-2021
10.6.5 GlaxoSmithKline Product Offered
10.7 Pfizer
10.7.1 Pfizer Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.7.2 Pfizer Sales, Value, Gross and Gross Margin from 2014-2021
10.7.3 Pfizer Value and Growth Change from 2014-2021
10.7.4 Pfizer Price Change from 2014-2021
10.7.5 Pfizer Product Offered
10.8 Sanofi
10.8.1 Sanofi Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.8.2 Sanofi Sales, Value, Gross and Gross Margin from 2014-2021
10.8.3 Sanofi Value and Growth Change from 2014-2021
10.8.4 Sanofi Price Change from 2014-2021
10.8.5 Sanofi Product Offered
10.9 Teva Pharmaceutical Industries
10.9.1 Teva Pharmaceutical Industries Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.9.2 Teva Pharmaceutical Industries Sales, Value, Gross and Gross Margin from 2014-2021
10.9.3 Teva Pharmaceutical Industries Value and Growth Change from 2014-2021
10.9.4 Teva Pharmaceutical Industries Price Change from 2014-2021
10.9.5 Teva Pharmaceutical Industries Product Offered
10.10 Merck
10.10.1 Merck Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.10.2 Merck Sales, Value, Gross and Gross Margin from 2014-2021
10.10.3 Merck Value and Growth Change from 2014-2021
10.10.4 Merck Price Change from 2014-2021
10.10.5 Merck Product Offered
10.11 Boston Scientific Corporation
10.11.1 Boston Scientific Corporation Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.11.2 Boston Scientific Corporation Sales, Value, Gross and Gross Margin from 2014-2021
10.11.3 Boston Scientific Corporation Value and Growth Change from 2014-2021
10.11.4 Boston Scientific Corporation Price Change from 2014-2021
10.11.5 Boston Scientific Corporation Product Offered
10.12 Teleflex Incorporated
10.12.1 Teleflex Incorporated Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.12.2 Teleflex Incorporated Sales, Value, Gross and Gross Margin from 2014-2021
10.12.3 Teleflex Incorporated Value and Growth Change from 2014-2021
10.12.4 Teleflex Incorporated Price Change from 2014-2021
10.12.5 Teleflex Incorporated Product Offered
10.13 Endo International
10.13.1 Endo International Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.13.2 Endo International Sales, Value, Gross and Gross Margin from 2014-2021
10.13.3 Endo International Value and Growth Change from 2014-2021
10.13.4 Endo International Price Change from 2014-2021
10.13.5 Endo International Product Offered
10.14 Urologix
10.14.1 Urologix Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.14.2 Urologix Sales, Value, Gross and Gross Margin from 2014-2021
10.14.3 Urologix Value and Growth Change from 2014-2021
10.14.4 Urologix Price Change from 2014-2021
10.14.5 Urologix Product Offered
10.15 LISA Laser
10.15.1 LISA Laser Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.15.2 LISA Laser Sales, Value, Gross and Gross Margin from 2014-2021
10.15.3 LISA Laser Value and Growth Change from 2014-2021
10.15.4 LISA Laser Price Change from 2014-2021
10.15.5 LISA Laser Product Offered
10.16 Olympus
10.16.1 Olympus Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.16.2 Olympus Sales, Value, Gross and Gross Margin from 2014-2021
10.16.3 Olympus Value and Growth Change from 2014-2021
10.16.4 Olympus Price Change from 2014-2021
10.16.5 Olympus Product Offered
11. Market Dynamics
11.1 Driving Factors
11.1.1 Rising Demand in Some Regions: North America/Europe/China/India/Japan …
11.1.2 Increasing Use of Benign Prostatic Hyperplasia Treatment by Different End-User/Applications
11.2 Restraints and Challenges in the Market
11.3 Opportunities
11.4 Covid-19 Impact/Evaluation
12. Future Forecast of Global Benign Prostatic Hyperplasia Treatment Market from 2020-2026
12.1 Future Forecast of Global Benign Prostatic Hyperplasia Treatment Market from 2020-2026 Segment by Regions
12.2 Future Forecast of Global Benign Prostatic Hyperplasia Treatment Market from 2020-2026 Segment by Type
12.3 Future Forecast of Global Benign Prostatic Hyperplasia Treatment Market from 2020-2026 Segment by Application
13. Investment Analysis
13.1 Fundamental Analysis (Porter's Five Forces Analysis)
13.2 Technical Preparation Analysis
13.3 Risk Evaluating Analysis
13.4 Estimated Investment Pay-Back Period
14 Research Methodology
14.1 Research Data
14.1.1 Secondary Data
14.1.2 Primary Data
14.2 Revenue Estimation
14.2.1 Bottom-Up Approach
14.2.2 Top-Down Approach (Involves time, Space, and Persons)
14.3 Data Triangulation
14.4 Assumptions
14.5 Hypothesis of this Research, Clear, specific, and testable statement of this research
14.6 Limitations of Our Study
14.7 Scene Based Modeling
15 Disclaimer
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|